Using the DGIdb database, four key NLRP3 inflammasome-related genes (APP, HSP90AB1, NFKB and TLR4) were further selected as potential druggable targets for Crohn’s disease treatment (Figure 11B). Here, TLR4 is linked to Crohn disease.